Send me a link:

*Text messaging rates may apply.

 Dow Down 0.16% Nasdaq Up 0.40%

TrovaGene, Inc. (TROV)

-NasdaqCM
3.26 0.07(2.19%) Jul 23, 3:59PM EDT
Prev Close:3.19
Open:3.24
Bid:3.05 x 1600
Ask:3.45 x 100
1y Target Est:9.50
Beta:-2.35
Next Earnings Date:N/A
Day's Range:3.20 - 3.29
52wk Range:3.15 - 10.27
Volume:67,767
Avg Vol (3m):68,744
Market Cap:61.62M
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for TROV

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):240.16
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.85
Quarterly EPS Est (Jun-14) :-0.21
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trovagene, Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of a proprietary urine-based molecular diagnostic technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback